DTC
Deep Track Capital Portfolio holdings
AUM
$3.11B
This Quarter Return
+31.38%
1 Year Return
+13.6%
3 Year Return
+265.73%
5 Year Return
–
10 Year Return
–
AUM
$2.02B
AUM Growth
+$2.02B
(+40%)
Cap. Flow
+$255M
Cap. Flow
% of AUM
12.6%
Top 10 Holdings %
Top 10 Hldgs %
42.84%
Holding
68
New
16
Increased
12
Reduced
21
Closed
5
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$90.5M |
| 2 |
Ascendis Pharma
ASND
|
$82.6M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$67.6M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$48.1M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$44.9M |
Top Sells
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$226M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$64.8M |
| 3 |
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
|
$61.5M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$24.4M |
| 5 |
Keros Therapeutics
KROS
|
$18.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRNA
26
Verona Pharma
VRNA
$9.16B
| $28.9M | 1.32% | +2,829,094 | New | +$28.9M |
|
|
ALLK
27
DELISTED
Allakos
ALLK
| $27.7M | 1.27% | +4,518,575 | New | +$27.7M |
|
28
Akero Therapeutics
AKRO
$3.74B
| $26.9M | 1.23% | +790,926 | New | +$26.9M |
|
29
Nurix Therapeutics
NRIX
$714M
| $26.8M | 1.23% | 2,053,621 -382,543 | -16% | -$4.98M |
|
|
VERV
30
DELISTED
Verve Therapeutics
VERV
| $26.6M | 1.22% | +775,000 | New | +$26.6M |
|
31
KalVista Pharmaceuticals
KALV
$678M
| $26.5M | 1.21% | 1,824,000 | – | – |
|
32
4D Molecular Therapeutics
FDMT
$288M
| $25.7M | 1.18% | 3,196,642 +56,642 | +2% | +$455K |
|
|
THRD
33
DELISTED
Third Harmonic Bio
THRD
| $24.1M | 1.1% | +1,268,220 | New | +$24.1M |
|
|
GBT
34
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $22.2M | 1.02% | 326,600 -3,320,090 | -91% | -$226M |
|
|
VIGL
35
DELISTED
Vigil Neuroscience
VIGL
| $21.5M | 0.98% | 2,363,188 +2,054,795 | +666% | +$18.7M |
|
|
ALBO
36
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $21.5M | 0.98% | +1,110,624 | New | +$21.5M |
|
37
Nuvation Bio
NUVB
$1.02B
| $20.9M | 0.96% | 9,325,540 -2,145,741 | -19% | -$4.81M |
|
38
Crinetics Pharmaceuticals
CRNX
$2.92B
| $20.7M | 0.95% | 1,053,000 | – | – |
|
|
DICE
39
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $20.3M | 0.93% | 1,000,000 -42,900 | -4% | -$870K |
|
|
SLN
40
Silence Therapeutics
SLN
$227M
| $19.6M | 0.9% | 1,951,580 +1,000,000 | +105% | +$10M |
|
|
FMTX
41
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $19.3M | 0.88% | 966,573 -3,083,427 | -76% | -$61.5M |
|
42
Ardelyx
ARDX
$1.53B
| $17.7M | 0.81% | +14,858,000 | New | +$17.7M |
|
43
Relmada Therapeutics
RLMD
$37.2M
| $17.1M | 0.78% | 460,861 -39,139 | -8% | -$1.45M |
|
44
Intellia Therapeutics
NTLA
$1.22B
| $16.8M | 0.77% | +300,000 | New | +$16.8M |
|
45
89bio
ETNB
$1.34B
| $15.3M | 0.7% | +2,636,000 | New | +$15.3M |
|
|
TCDA
46
DELISTED
Tricida, Inc. Common Stock
TCDA
| $12.3M | 0.57% | 1,177,680 -1,554,437 | -57% | -$16.3M |
|
47
Adicet Bio
ACET
$59.9M
| $11.7M | 0.54% | 825,508 -66,520 | -7% | -$946K |
|
|
JNCE
48
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $9.97M | 0.46% | 4,259,653 | – | – |
|
|
49
Keros Therapeutics
KROS
$618M
| $9.35M | 0.43% | 248,500 -491,028 | -66% | -$18.5M |
|
50
AnaptysBio
ANAB
$569M
| $9.18M | 0.42% | 360,000 -312,569 | -46% | -$7.97M |
|